Compounds > pyrimethamine
Page last updated: 2024-08-16

pyrimethamine and podophyllotoxin

pyrimethamine has been researched along with podophyllotoxin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bongard, E; Brown, DM; Loakes, D; Too, K; Vivas, L; Yardley, V1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Charman, SA; Chibale, K; Fakorede, F; Gessner, RK; Gitari, PW; Hudson, A; Kaiser, M; Ndakala, AJ; October, N; Shackleford, DM; White, KL; Yeates, C1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1

Other Studies

4 other study(ies) available for pyrimethamine and podophyllotoxin

ArticleYear
Anti-malarial activity of N6-modified purine analogues.
    Bioorganic & medicinal chemistry, 2007, Aug-15, Volume: 15, Issue:16

    Topics: Animals; Antimalarials; Male; Mice; Molecular Structure; Plasmodium falciparum; Purines; Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Antimalarial pyrido[1,2-a]benzimidazoles.
    Journal of medicinal chemistry, 2011, Jul-14, Volume: 54, Issue:13

    Topics: Administration, Oral; Animals; Antimalarials; Benzimidazoles; Drug Resistance, Multiple; Humans; In Vitro Techniques; Injections, Intraperitoneal; L Cells; Malaria; Male; Mice; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2011
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016